Trial results offer clinically important information on the efficacy and safety of the combination therapy in CKD with type 2 diabetes.

Adding an SGLT2 inhibitor to finerenone in CKD and type 2 diabetes yields “remarkable” albuminuria reductions that may, if ...

Novo Nordisk has announced plans to move its ziltivekimab into phase 3 clinical development in atherosclerosis with chronic kidney disease after a mid-stage trial met its main goal.

The first phase includes industrial land allocation services, which will be provided through an investment map and by issuing operating licenses with annual notification and follow-up. The ...

June 10, 2025 — Acetaminophen may be doing more than just dulling pain in your brain it could be stopping it before it even starts. Scientists at Hebrew University have discovered that a ...

President Trump's meeting with German Chancellor Friedrich Merz will take place amid a backdrop of tensions between the U.S. and Europe over trade and Ukraine.